Pulmonary Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Your baby was born at 34 weeks of pregnancy or later
- Your baby has breathing problems caused by low oxygen levels that have needed breathing machine support for more than 24 hours
- Your baby has signs of high blood pressure in the lungs, either from a clinical assessment or from a heart ultrasound (echocardiogram) showing specific measurements (confirm with trial site)
- Your baby is less than 7 days old when the study treatment would begin
- You (as the baby's guardian) agree to take part and sign a consent form
Who may not be able to join:
- Your baby's body depends on a specific abnormal blood flow pattern to survive (confirm with trial site)
- Your baby's mother received blood-thinning medications during pregnancy
- Your baby's heart ultrasound shows a particular type of abnormal blood flow or a weakened left side of the heart (confirm with trial site)
- Your baby urgently needs, or has already received, a special life-support machine called ECMO
- Your baby is expected to pass away within the next 24 hours
- Your baby has a serious life-threatening physical abnormality affecting the head, heart, or chest
- Your baby has a chromosomal condition (such as Down syndrome or similar)
- Your baby was born with a hole in the diaphragm (the muscle separating the chest and belly)
- Your baby has a heart defect present from birth (apart from certain minor, common ones)
- Your baby needed chest compressions during resuscitation within 6 hours before the study treatment would start
- Your baby has serious bleeding problems, such as severe brain bleeding or uncontrolled bleeding
- Your baby has a blood-clotting disorder called disseminated intravascular coagulopathy
- Your baby is having active seizures while already receiving anti-seizure medication
- Your baby experienced a prolonged lack of oxygen with signs of severe acid buildup in the blood
- Your baby is currently receiving certain medications that release nitric oxide, such as prilocaine, sodium nitroprusside, nitroglycerin, or sulfonamides
- The trial doctor decides for any other reason that your baby is not suitable for the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-18017591123
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To evaluate the safety of inhaled nitric oxide combined with ventilatory support in the treatment of neonatal (≥ 34 weeks gestational age) hypoxic respiratory failure with pulmonary hypertension.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.